NCT05329350View on ClinicalTrials.gov

Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

March 3, 2026

Study Completion Date

October 1, 2029

Conditions
Muscular Ventricular Septal Defect
Interventions
DEVICE

muscular ventricular septal defects

intervention cardiology and structural heart disease, including transseptal puncture.

Trial Locations (1)

27310

RECRUITING

Gaziantep Unıversıty Hospital, Gaziantep

Sponsors
All Listed Sponsors
lead

Occlutech International AB

INDUSTRY